The Tamil Nadu Dr. MGR Medical University has developed a vaccine candidate (i.e. potential vaccine) against SARS-CoV-2 (Covid-19) through ‘reverse vaccinology.
Reverse vaccinology helps in the examination of the genome of an organism in order to identify novel antigens and epitopes that might constitute vaccine candidates. The process includes comparative in silico analyses of multiple genome sequences in order to identify conserved antigens within a heterogeneous pathogen population and identification of antigens that are unique to pathogenic isolates but not present in commensal strains.
Previously, Reverse vaccinology has been used for developing vaccinations for meningococcal and staphylococcal infections. In addition, transcriptomic and proteomic data sets are integrated into a selection process that yields a shortlist of candidate antigens to be tested in animal models, thus reducing the costs and time of downstream analyses.